Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

100620

registered interest
date	23/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government how the Secretary of State for Health has discharged his duty to report on the treatment of National Health Service health care providers as specified in section 8 of the Health and Social Care Act 2012.
tabling member printed	Lord Hunt of Kings Heath
uin	HL2351
answer	answer is ministerial correction date of answer 31/10/2014 answer text <p>The Secretary of State commissioned Monitor to lead a Fair Playing Field Review into the equal treatment of providers of National Health Service services. The Review published its final Report in March 2013. Since publication, Monitor has established a high level implementation group, of which the Department is a member, to take forward the Review’s recommendations.</p><p> </p><p><strong> </strong></p><p> </p><p>As part of its annual assurance processes the Department seeks confirmation from all its Directors General that they and our Arm’s Length Bodies have taken the duty into consideration, as outlined in Section 8 of the Health and Social Care Act 2012.</p><p> </p> answering member printed Earl Howe question first answered 31/10/2014 13:18:46 answering member 2000 label Biography information for Earl Howe
tabling member	2024 label Biography information for Lord Hunt of Kings Heath

100623

registered interest
date	23/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	NHS: Cost Effectiveness
house id	2
legislature	25277 pref label House of Lords
question text	To ask Her Majesty’s Government whether the "Nicholson Challenge" still operates within the National Health Service; if so, what efficiency savings have been identified to date; and, if not, why not.
tabling member printed	Lord Sharkey
uin	HL2354
answer	answer is ministerial correction date of answer 30/10/2014 answer text <p>The 2010 Spending Review protected health funding in real terms. However, in order to continue to meet rising demands while improving services, it was estimated that up to £20 billion of efficiency savings would be required over the four years from 2011-12 to 2014-15.</p><p> </p><p> </p><p> </p><p>The National Health Service response to this challenge was organised through the Quality, Innovation, Productivity and Prevention (QIPP) initiative, also known colloquially as the ‘Nicholson challenge’ after Sir David Nicholson, who was Chief Executive of the NHS at the time that QIPP originated.</p><p> </p><p> </p><p> </p><p>The NHS is on track to deliver up to £20 billion efficiency savings, having reported around £15 billion of efficiencies in the first three years, all of which will be reinvested into frontline care.</p><p> </p> answering member printed Earl Howe question first answered 30/10/2014 12:11:13 answering member 2000 label Biography information for Earl Howe
tabling member	4196 label Biography information for Lord Sharkey

100397

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Hepatitis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, with reference to the Answers of 30 March 2011, Official Report, column 399W, to the hon. Member for Colne Valley, and of 28 March 2011, Official Report, House of Lords, column WA217, to Lord Morris of Manchester, whether, when the dependents and widows of those who contracted hepatitis C following treatment with NHS blood products, but who died before 29 August 2003, were given the opportunity to apply for Skipton Fund lump sum payments during a two month period in January to March 2011 the fact that (a) registrations made after the 31 March 2011 deadline could be accepted on a case-by-case basis where there was a valid reason for the applicant to have missed the registration deadline and (b) applicants needed only to register with the fund by the deadline and could compile the necessary medical evidence later were communicated through the channels listed in Deposited Paper DEP2011-0543.
tabling member constituency	Kingston upon Hull North
tabling member printed	Diana Johnson
uin	211655
answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>The decision that claims to the Skipton Fund in respect of people who died before 29 August 2003 could be registered after 31 March 2011 on a case-by-case basis, where there was a valid reason for the applicant to have missed the registration deadline, was communicated by the Skipton Fund on its website. It was not communicated through the other channels listed in Deposited Paper DEP2011-0543.</p><p> </p><p><strong> </strong></p><p> </p><p>The Skipton Fund website still states that it is possible to apply for payments on behalf of the estate of someone who died prior to 29 August 2003, but claimants are asked to contact the Skipton Fund to discuss whether the claimant has a valid reason for missing the original deadline for registering claims of 31 March 2011. <br> <br></p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 29/10/2014 17:38:11 answering member 3918 label Biography information for Jane Ellison
tabling member	1533 label Biography information for Dame Diana Johnson

100398

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Motor Neurone Disease: North West
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what assessment he has made of the adequacy of the availability of augmentative and alternative communication aids for sufferers of motor neurone disease in (a) East Lancashire and (b) the North West.
tabling member constituency	Pendle
tabling member printed	Andrew Stephenson
uin	211529
answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>Since April 1 2013 NHS England has been responsible for commissioning Alternative and Augmentative Communication (AAC) aids for patients with complex disability whose needs require specialised assessment, including for patients with motor neurone disease (MND). Commissioning of non-specialised AAC aids is the responsibility of local clinical commissioning groups.</p><p> </p><p> </p><p> </p><p>NHS England has published a service specification for specialised AAC aids that sets out what should be in place for providers to offer evidence-based, safe and effective services and supports equity of access to a nationally consistent, high quality service for patients across the country including in East Lancashire and the North West. The specification can be found at:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/d01-com-dis-equ-alt-aug-comm-aids.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/d01-com-dis-equ-alt-aug-comm-aids.pdf</a></p><p> </p><p> </p><p> </p><p>NHS England has identified an additional £22.5 million funding for AAC and Environmental Controls in 2014-15. They have been working closely with the Motor Neurone Disease Association (MNDA) to ensure this funding is equitably distributed across England in a fair and consistent manner. The MNDA are representing all patients on the panel which is reviewing this funding allocation.</p><p> </p><p> </p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 29/10/2014 15:33:32 answering member 1439 label Biography information for Norman Lamb
tabling member	4044 label Biography information for Andrew Stephenson

100399

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Dementia: Pendle
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many people in Pendle constituency have been diagnosed with dementia in each year since 2006-07.
tabling member constituency	Pendle
tabling member printed	Andrew Stephenson
uin	211530
answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>Information is not available in the format requested. The number of people on the dementia register is available. This is a measure of prevalence rather than incidence. The number of people recorded on practice disease registers is taken from the Quality and Outcomes Framework (QOF), published by the Health and Social Care Information Centre. The following table shows all available data for East Lancashire Primary Care Trust (PCT) and East Lancashire Clinical Commissioning Group (CCG) as these cover the Pendle constituency.</p><p> </p><p><strong> </strong></p><p> </p><p>Number of patients on the QOF dementia register for East Lancashire Clinical Commissioning Group/Primary Care Trust</p><p> </p><p> </p><p> </p><table><tbody><tr><td><p> </p></td><td><p>Practices<sup>1</sup></p></td><td><p>Practice List size<sup>1</sup></p></td><td><p>Number of patients on Dementia Register<sup>1</sup></p></td></tr><tr><td><p>East Lancashire CCG</p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>2013-14<sup>2</sup></p></td><td><p>59</p></td><td><p>371,608</p></td><td><p>2,323</p></td></tr><tr><td><p>2012-13</p></td><td><p>61</p></td><td><p>367,891</p></td><td><p>2,197</p></td></tr><tr><td><p> </p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>East Lancashire PCT</p></td><td><p> </p></td><td><p> </p></td><td><p> </p></td></tr><tr><td><p>2011-12</p></td><td><p>65</p></td><td><p>386,187</p></td><td><p>2,183</p></td></tr><tr><td><p>2010-11</p></td><td><p>67</p></td><td><p>388,324</p></td><td><p>1,975</p></td></tr><tr><td><p>2009-10</p></td><td><p>67</p></td><td><p>388,267</p></td><td><p>1,848</p></td></tr><tr><td><p>2008-09</p></td><td><p>65</p></td><td><p>388,345</p></td><td><p>1,715</p></td></tr><tr><td><p>2007-08</p></td><td><p>65</p></td><td><p>387,543</p></td><td><p>1,774</p></td></tr><tr><td><p>2006-07</p></td><td><p>65</p></td><td><p>386,260</p></td><td><p>1,744</p></td></tr></tbody></table><p> </p><p><strong> </strong></p><p> </p><p><sup>1</sup> Practices, Practice List sizes and Number of patients on Dementia Register are based only on those GP practices that participated in QOF.</p><p> </p><p> </p><p> </p><p><sup>2</sup> Information for 2013-14 is based only on those practices that participated in QOF in both 2012-13 and 2013-14. Therefore, 2013-14 figures are provisional and are subject to change once the full QOF is published 28 October 2014.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 29/10/2014 14:42:30 answering member 1439 label Biography information for Norman Lamb
tabling member	4044 label Biography information for Andrew Stephenson

100400

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Pancreatic Cancer
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that the NHS improves the diagnosis and treatment of pancreatic cancer.
tabling member constituency	Birkenhead
tabling member printed	Mr Frank Field
uin	211514
answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>Achieving earlier diagnosis of cancer is key to our ambition to save an additional 5,000 lives per year by 2014-15. We are investing £450 million to achieve early diagnosis of cancer through better public awareness, better screening and better access to key diagnostic tests. However we know that early diagnosis of pancreatic cancer can be very difficult as the symptoms are shared with a wide range of benign conditions.</p><p> </p><p> </p><p> </p><p>The National Institute for Health and Care Excellence (NICE) Referral Guidelines for Suspected Cancer (2005) are available to help general practitioners assess when it is appropriate to refer patients for suspected cancer, including pancreatic cancer. NICE is in the process of updating the guidelines to ensure that these reflect latest evidence and can continue to support general practitioners (GPs) to identify patients with suspected cancer symptoms and urgently refer them as appropriate. NICE’s anticipated publication date for the revised guidelines is May 2015.</p><p> </p><p> </p><p> </p><p>We understand that NHS England has asked NICE to develop a clinical guideline and quality standard on pancreatic cancer.</p><p> </p><p> </p><p> </p><p>At a local level, it is for individual clinical commissioning groups to promote and enhance the diagnostic capability to deliver better outcomes. Surgery, radiotherapy and chemotherapy treatments that may be used for pancreatic cancer are commissioned at the moment by NHS England. NHS England’s pancreatic cancer service specification clearly defines what it expects to be in place for providers to offer evidence-based, safe and effective pancreatic cancer services. This service specification has been developed by specialised clinicians, commissioners, expert patients and public health representatives to describe core and developmental service standards.</p><p> </p><p> </p><p> </p><p>NHS England has also committed to make up to £6 million available over the next three years to support six trials by Cancer Research UK into the use of Stereotactic Ablative Radiotherapy (SABR), an innovative radiotherapy treatment. This will allow patients to receive SABR treatment now, where clinicians think they could benefit. At the same time doctors can fully assess the effectiveness of these treatments so that in future, if it proves to be effective, they will be available for all relevant patients on the NHS. One of these six trials will be on pancreatic cancer.</p><p> </p><p><strong> </strong></p><p> </p><p>The Department published Improving Outcomes for Upper Gastro-Intestinal Cancers in 2001, which describes best practice in the delivery of services for patients with all types of upper gastro-intestinal cancer, including pancreatic cancer.<br> <br> NICE has recommended gemcitabine as a treatment option for pancreatic cancer in technology appraisal guidance published in May 2001, subject to certain clinical criteria and is currently appraising a number of other pancreatic cancer drugs. Patients have the right to drugs and treatments that have been recommended by NICE technology appraisal guidance for use in the National Health Service, where their doctor believes they are clinically appropriate. <br> <br> A number of drugs to treat pancreatic cancers are also available through the Cancer Drugs Fund.</p><p> </p><p> </p><p> </p><p> </p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 29/10/2014 16:58:52 answering member 3918 label Biography information for Jane Ellison
tabling member	478 label Biography information for Lord Field of Birkenhead

100401

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Motor Neurone Disease
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he is taking to ensure that the NHS is meeting the communication needs of people with motor neurone disease.
tabling member constituency	Birkenhead
tabling member printed	Mr Frank Field
uin	211515
answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>Since 1 April 2013 NHS England has been responsible for commissioning Alternative and Augmentative Communication (AAC) aids for patients with complex disability whose needs require specialised assessment, including for patients with motor neurone disease. Commissioning of non-specialised AAC aids is the responsibility of local clinical commissioning groups.</p><p> </p><p> </p><p> </p><p>NHS England has published a service specification for specialised AAC aids that sets out what should be in place for providers to offer evidence-based, safe and effective services. The specification can be found at:</p><p> </p><p> </p><p> </p><p><a href="http://www.england.nhs.uk/wp-content/uploads/2013/06/d01-com-dis-equ-alt-aug-comm-aids.pdf" target="_blank">www.england.nhs.uk/wp-content/uploads/2013/06/d01-com-dis-equ-alt-aug-comm-aids.pdf</a></p><p> </p><p> </p><p> </p><p>NHS England has identified an additional £22.5 million funding for AAC and Environmental Controls in 2014-15. They have been working closely with the Motor Neurone Disease Association (MNDA) to ensure this funding is equitably distributed across England in a fair and consistent manner. The MNDA are representing all patients on the panel which is reviewing this funding allocation.</p><p> </p> answering member constituency North Norfolk answering member printed Norman Lamb question first answered 29/10/2014 17:16:16 answering member 1439 label Biography information for Norman Lamb
tabling member	478 label Biography information for Lord Field of Birkenhead

100402

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Paralysis
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps he has taken to support University College London in its work to enable people who have been paralysed to regain the ability to walk.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	211576
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>The Department’s National Institute for Health Research (NIHR) funds 11 biomedical research centres that conduct translational research to transform scientific breakthroughs into benefits for patients. These centres are formed through partnerships between England’s leading National Health Service organisations and universities.</p><p> </p><p> </p><p> </p><p>The NIHR is investing £110 million over five years (2012-17) in the NIHR biomedical research centre at University College London Hospitals NHS Foundation Trust and University College London. The centre is supporting research on the use of cells from the lining of the nose to repair damaged nerves in the spinal cord.</p><p> </p><p><strong> </strong></p><p> </p> answering member constituency Mid Norfolk answering member printed George Freeman question first answered 27/10/2014 16:53:22 answering member 4020 label Biography information for George Freeman
tabling member	4131 label Biography information for Jim Shannon

100403

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Perinatal Mortality
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, what steps the NHS takes to assist mothers of stillborn children to come to terms with their grief.
tabling member constituency	Strangford
tabling member printed	Jim Shannon
uin	211575
answer	answer is ministerial correction date of answer 27/10/2014 answer text <p>The National Health Service locally should ensure that appropriate facilities and services are in place to support bereaved parents following the death of a baby. In line with the Nursing and Midwifery Council’s Standards of proficiency for pre-registration midwifery education, all midwives should be proficient in providing care for women who have suffered pregnancy loss, stillbirth or neonatal death. Health Education England has agreed to work with partners to ensure that pre and post registration training in perinatal mental health is available to enable specialist staff to be available to every birthing unit by 2017.</p><p>To assist NHS commissioners and providers, the Royal College of Obstetricians and Gynaecologists’ Standards for Gynaecology and Standards for Maternity sets out clear standards for the level of care provided to help women and their partners experiencing pregnancy loss, including the availability of skilled staff to support parents following a stillbirth or miscarriage. A number of trusts now employ specialist bereavement midwives to provide this support.</p><p>To further assist NHS maternity services, NHS Improving Quality published ‘A review of support available for loss in early and late pregnancy’ in February 2014, which highlights areas of good practice and additional sources of support, such as the stillbirth and neonatal death charity, Sands.</p><p>Local NHS maternity care providers are responsible for ensuring parents receive appropriate information on bereavement support and services following the death of a baby. To complement information provided locally, information on support for parents after a stillbirth is available on the NHS Choices website at:</p><p>www.nhs.uk/Conditions/Stillbirth/Pages/Getting-help.aspx</p> answering member constituency Central Suffolk and North Ipswich answering member printed Dr Daniel Poulter question first answered 27/10/2014 16:51:15 answering member 3932 label Biography information for Dr Dan Poulter
tabling member	4131 label Biography information for Jim Shannon

100404

registered interest
date	22/10/2014
answering body	Department of Health
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Obesity: Pendle
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health, how many (a) men and (b) women in Pendle constituency were classified as (i) overweight and (ii) obese in each of the last 10 years.
tabling member constituency	Pendle
tabling member printed	Andrew Stephenson
uin	211556
answer	answer is ministerial correction date of answer 29/10/2014 answer text <p>Data on adult obesity and excess weight (overweight and obese) for Pendle district are available from the ‘Local Health Profiles’ using data from the ‘Active People Survey’ commissioned by Sport England. The data are only available for 2012 and are presented as a total figure for males and females. This data is not collected by parliamentary constituency. The following data are for the area of Pendle district.</p><p> </p><p> </p><p> </p><p>Excess weight defined as the proportion of the adult population who are overweight or obese for Pendle district in 2012 was 67.7% (England 63.8%).</p><p> </p><p> </p><p> </p><p>The proportion of the adult population in Pendle district classified as obese in 2012 was 25.3% (England 23.0%).</p><p> </p> answering member constituency Battersea answering member printed Jane Ellison question first answered 29/10/2014 17:41:28 answering member 3918 label Biography information for Jane Ellison
tabling member	4044 label Biography information for Andrew Stephenson